Conditioning with Treosulfan and Fludarabine Followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

In this prospective study 60 patients of median age 46 (range 5–60) years, with acute myeloid leukemia (AML; n=44), acute lymphoblastic leukemia (ALL; n=3), or myelodysplastic syndrome (MDS; n=13) were conditioned for allogeneic hematopoietic cell transplantation with a treosulfan/fludarabine combin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Nemecek, Eneida R., Guthrie, Katherine A., Sorror, Mohamed L., Wood, Brent L., Doney, Kristine C., Hilger, Ralf A., Scott, Bart L., Kovacsovics, Tibor J., Maziarz, Richard T., Woolfrey, Ann E., Bedalov, Antonio, Sanders, Jean E., Pagel, John M., Sickle, Eileen J., Witherspoon, Robert, Flowers, Mary E., Appelbaum, Frederick R., Deeg, H. Joachim
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2974965/
https://ncbi.nlm.nih.gov/pubmed/20685259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.05.007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller